These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2898843)

  • 1. Safe, live Vibrio cholerae vaccines?
    Taylor R; Shaw C; Peterson K; Spears P; Mekalanos J
    Vaccine; 1988 Apr; 6(2):151-4. PubMed ID: 2898843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.
    Attridge SR; Voss E; Manning PA
    J Biotechnol; 1999 Aug; 73(2-3):109-17. PubMed ID: 10486921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
    Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF
    Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.
    Hauke CA; Taylor RK
    PLoS One; 2017; 12(4):e0175170. PubMed ID: 28384206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.
    Butterton JR; Boyko SA; Calderwood SB
    Vaccine; 1993 Oct; 11(13):1327-35. PubMed ID: 8296486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization.
    Peterson KM; Mekalanos JJ
    Infect Immun; 1988 Nov; 56(11):2822-9. PubMed ID: 2902009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
    Kaper JB; Levine MM
    Res Microbiol; 1990; 141(7-8):901-6. PubMed ID: 2101480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
    Cryz SJ; Kaper J; Tacket C; Nataro J; Levine MM
    Dev Biol Stand; 1995; 84():237-44. PubMed ID: 7796960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tcpB Mutations on Biogenesis and Function of the Toxin-Coregulated Pilus, the Type IVb Pilus of Vibrio cholerae.
    Gao Y; Hauke CA; Marles JM; Taylor RK
    J Bacteriol; 2016 Oct; 198(20):2818-28. PubMed ID: 27481929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model.
    Sharma DP; Stroeher UH; Thomas CJ; Manning PA; Attridge SR
    Microb Pathog; 1989 Dec; 7(6):437-48. PubMed ID: 2576091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization.
    Chiang SL; Mekalanos JJ
    Mol Microbiol; 1998 Feb; 27(4):797-805. PubMed ID: 9515705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New attenuated derivatives of Vibrio cholerae.
    Pearson GD; DiRita VJ; Goldberg MB; Boyko SA; Calderwood SB; Mekalanos JJ
    Res Microbiol; 1990; 141(7-8):893-9. PubMed ID: 2101479
    [No Abstract]   [Full Text] [Related]  

  • 14. Secretion of a soluble colonization factor by the TCP type 4 pilus biogenesis pathway in Vibrio cholerae.
    Kirn TJ; Bose N; Taylor RK
    Mol Microbiol; 2003 Jul; 49(1):81-92. PubMed ID: 12823812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tcp gene cluster of Vibrio cholerae.
    Manning PA
    Gene; 1997 Jun; 192(1):63-70. PubMed ID: 9224875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular design of cholera vaccines.
    Manning PA
    Vaccine; 1992; 10(14):1015-21. PubMed ID: 1361701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live oral vaccines against cholera: an update.
    Levine MM; Kaper JB
    Vaccine; 1993; 11(2):207-12. PubMed ID: 8438619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
    Levine MM; Kaper JB; Herrington D; Losonsky G; Tacket C; Tall B
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):401-15. PubMed ID: 3217822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Vibrio cholerae type 4 prepilin peptidase required for cholera toxin secretion and pilus formation.
    Marsh JW; Taylor RK
    Mol Microbiol; 1998 Sep; 29(6):1481-92. PubMed ID: 9781884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.